NCT00518869 - Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

December 31, 2009

Conditions

Quality of LifeFatigueComplementary

Interventions

DRUG

PG2

500 mg PG2 / 500 ml normal saline IV infusion for 3 hours once daily for 4 doses in the 1st week, 3 doses in the 2nd week and 3 doses in the 3rd week of each chemo-cycle for three cycles. Total 10 doses will be given in each cycle even with skip days.

Trial Locations (10)

Unknown

Changhua Christian Hospital, Changhua

Chang-Gung Memorial Hospital - Kaoshiung, Kaohsiung City

Kaoshiung Medical University Hospital, Kaohsiung City

Chang-Gung Memorial Hospital, Linkou, Linkou District

China Medical University Hospital, Taichung

Taichung Veterans General Hospital, Taichung

National Cheng-Kung University Hospital, Tainan City

Mackay Memorial Hospital, Taipei

Taipei Veterans General Hospital, Taipei

Tri-Service General Hospital, Taipei